- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GeneOne Life Science Inc (011000)
GeneOne Life Science Inc stock price live, this page displays KS 011000 stock exchange data. View the 011000 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GeneOne Life Science Inc real time stock price chart below.
What Is the GeneOne Life Science Inc Stock Price Today?
The GeneOne Life Science Inc stock price today is 577.
What Is the Stock Symbol for GeneOne Life Science Inc?
The stock symbol for GeneOne Life Science Inc is "011000."
What Stock Exchange Does GeneOne Life Science Inc Trade On?
GeneOne Life Science Inc is listed and trades on the Seoul stock exchange.
Is GeneOne Life Science Inc a Good Stock to Buy?
Determining whether GeneOne Life Science Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 011000 quote. (ISIN: KR7011000007)
What Is the GeneOne Life Science Inc Stock Price Today?
The GeneOne Life Science Inc stock price today is 577.
What Is the Stock Symbol for GeneOne Life Science Inc?
The stock symbol for GeneOne Life Science Inc is "011000."
What Stock Exchange Does GeneOne Life Science Inc Trade On?
GeneOne Life Science Inc is listed and trades on the Seoul stock exchange.
Is GeneOne Life Science Inc a Good Stock to Buy?
Determining whether GeneOne Life Science Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 011000 quote. (ISIN: KR7011000007)
Seoul
Currency in KRW
577
-51(-8.12%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
555
634
52 wk Range
555
2,685
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
555634
52 wk Range
5552,685
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
011000 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Apr 07, 2026
EPS / Forecast
-196.00 / --
Revenue / Forecast
2.65B / --
Compare 011000 to Peers and Sector
Metrics to compare | 011000 | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship Relationship011000PeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −6.8x | −0.4x | |
PEG Ratio | −0.11 | 0.00 | 0.00 | |
Price/Book | 1.1x | 1.4x | 2.6x | |
Price / LTM Sales | 3.3x | 3.3x | 3.0x | |
Upside (Analyst Target) | - | 88.2% | 58.4% | |
Fair Value Upside | Unlock | 34.8% | 8.6% | Unlock |
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals. Its small molecule pipeline comprises GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company’s nucleic acid vaccines include GLS-3000 mRNA under feasible study and GLS-5310 DNA under phase 2 stage for the treatment of SARS-CoV-2; GLS-5100 under pre-clinical stage for prevention of herpes zoster; and GLS-5140 under pre-clinical stage for the treatment of SFTS prophylaxis. In addition, it is developing GLS-5300, which is in Phase II clinical trial for MERS; GLS-5700 that is in Phase I clinical trial for Zika; and GLS-6150, which is in Phase I clinical trial for treatment of hepatitis C re-infection prophylaxis, as well as GLS-6100 that is in pre-clinical stage for hepatitis C prophylaxis. Further, the company’s discovery and optimization stage pipeline comprise GLS-7000 for the treatment of breast cancer; GLS-7100 for treating hemophilia A; GLS-8000 for the prevention of chronic hepatitis B; and GLS-8100 for treating rheumatoid arthritis. Additionally, it engages in the cGMP production of nucleic acid-based products, including DNA plasmids and mRNA. The company was formerly known as VGX International Inc. and changed its name to GeneOne Life Science, Inc. in April 2014. GeneOne Life Science, Inc. was founded in 1976 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GeneOne Life Science (011000) Stock Price Today?
The GeneOne Life Science stock price today is 577 KRW.
What Stock Exchange Does GeneOne Life Science Trade On?
GeneOne Life Science is listed and trades on the Seoul Stock Exchange.
What Is the Stock Symbol for GeneOne Life Science?
The stock symbol for GeneOne Life Science is "011000."
What Is the GeneOne Life Science Market Cap?
As of today, GeneOne Life Science market cap is 56.94B KRW.
What Is GeneOne Life Science's Earnings Per Share (TTM)?
The GeneOne Life Science EPS (TTM) is -532.
From a Technical Analysis Perspective, Is 011000 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has GeneOne Life Science Stock Split?
GeneOne Life Science has split 14 times.
How Many Employees Does GeneOne Life Science Have?
GeneOne Life Science has 41 employees.
What is the current trading status of GeneOne Life Science (011000)?
As of Jun 23, 2026, GeneOne Life Science (011000) is trading at a price of 577 KRW, with a previous close of 628 KRW. The stock has fluctuated within a day range of 555 KRW to 634 KRW, while its 52-week range spans from 555 KRW to 2,685 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.